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Abstract
Serum- and glucocorticoid-inducible kinase 1 (SGK1) plays a central role in epithelial sodium
channel (ENaC)-dependent Na+ transport in the distal nephron. We hypothesized that SGK1 gene
variants may contribute to the effect of dietary salt intake on BP in humans with hypertension, and
consequentially influence renin-angiotensin-aldosterone (RAA) system activity. Our study
population included 421 hypertensive Caucasian participants of the HyperPath group who had
completed a dietary salt protocol with measurement of BP and RAA system activity. Three SGK1
tagging single nucleotide polymorphisms (SNPs) from the HapMap CEU population captured the
genetic variation in the SGK1 region. Assuming an additive genetic model, two SNPs (rs2758151
and rs9402571) were associated with BP and plasma renin activity (PRA) effects of dietary salt
intake. Major alleles were associated with higher systolic BP on high salt and decreased PRA on
low salt. In contrast, low salt neutralized genotype differences. Similar, non-significant trends
were observed in a normotensive population (N=152). Genotype was also associated with two
salt-sensitive subtypes of hypertension. SGK1 genetic variants are associated with salt sensitivity
of BP and PRA in human hypertension. Genotype status at these SGK1 variants may identify
individuals prone to salt-sensitive hypertension.
Keywords
SGK1; polymorphism; renin; salt sensitivity
INTRODUCTION
Serum- and glucocorticoid-inducible kinase 1 (SGK1) is an important regulator of epithelial
Na+ channel (ENaC) activity and its role in aldosterone-induced sodium reabsorption in the
kidney.1 SGK1 expression is regulated by changes in intravascular volume and by
mineralocorticoids.1, 2 Mice lacking the SGK1 gene are unable to appropriately increase the
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texpression and activity of ENaC leading to impaired sodium reabsorption and hypotension
on a sodium restricted diet resulting in sodium dependency to maintain blood pressure
(BP).3 In humans, increases in dietary salt intake lead to increased BP in some, but not all,
individuals regardless of hypertension.4,5 Variability within this BP response has been
attributed in part to gene-environment interactions.6
We hypothesized that SGK1 genetic polymorphisms in humans are associated with the BP
response to dietary salt intake, which in turn would result in altered renin-angiotensin-
aldosterone (RAA) system activity. To test this hypothesis, we genotyped tagging single
nucleotide polymorphisms (SNPs) in SGK1 in a group of hypertensive Caucasian
individuals who had undergone a rigorous dietary salt protocol including assessment of BP
and activity of the RAA system. We then explored whether these findings extended to a
separate normotensive Caucasian group who had completed the same protocol.
METHODS
International Hypertension Pathotypes (HyperPath) Group
The data reported in this study are from the International Hypertension Pathotypes
(HyperPath) Group. This group was formed in 1992 to characterize the genetic
underpinnings of human hypertension through an intermediate phenotyping approach—
common heritable traits within a population that define a subset while guiding candidate
gene selection.7 In order to enhance the ability to detect genetic differences, normotensives
in this study were included and were required to have no heritable tendency such as first-
degree relatives with hypertension, coronary artery disease, or diabetes mellitus.
Study Participants and Protocol
The primary study outcome was the BP response to dietary salt intake under high and low
salt conditions according to genotype status at SGK1. Data on 421 hypertensive Caucasian
study volunteers and 152 normotensive Caucasian study volunteers who had participated in
the International Hypertension Pathotype (HyperPath) group were analyzed. Details of this
group have been described previously, but the analyses presented in this manuscript are
original and not reported previously.4, 8, 9 Briefly, participants were studied on the Clinical
Research Centers (CRCs) of Brigham and Women’s Hospital in Boston, Massachusetts,
USA, University of Utah Medical Center in Salt Lake City, Utah, USA, Vanderbilt
University in Nashville, Tennessee, USA, Hospital Broussais in Paris, France and University
La Sapienza in Rome, Italy. The Institutional Review Board of each site approved the study
protocol and informed consent was obtained from all study participants prior to enrollment.
As per the original HyperPath study protocol, all study participants completed a screening
visit consisting of a physical examination, a medical history, and laboratory assessment.5
Study participants with a history of diabetes mellitus, any form of secondary hypertension,
overt renal insufficiency (serum creatinine >114μmol/L), or any significant medical or
psychiatric illnesses were excluded. Study participants with severe obesity (body mass index
>34kg m−2), current tobacco or illicit drug use, or alcohol intake >12 ounces per week were
also excluded. Normal laboratory values for electrolytes, thyroid and liver function tests
were required. Electrocardiographic evidence of heart block, ischemia, or previous coronary
events led to exclusion. Study participants had to be between 18 and 65 years of age and
race was self-defined. To minimize the interference of medication with our assessment of
RAA system activity, all angiotensin converting enzyme inhibitors, angiotensin receptor
blockers, or mineralocorticoid receptor antagonists were discontinued 3 months before the
study. If needed, study participants were placed on amlodipine or hydrochlorothiazide to
control blood pressure. Beta-blockers and diuretics were withdrawn 1 month before study
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tinitiation. All antihypertensive medications were discontinued 3 weeks prior to vascular and
hormonal assessment.
As per the original study design, hypertension was defined as a seated diastolic BP ≥100
mmHg off antihypertensive medication, ≥ 90mmHg while taking at least one
antihypertensive medication, or treatment with at least two antihypertensive medications.
Eligibility was determined while on an ad lib diet. Hypertensive individuals requiring more
than 3 antihypertensive agents were excluded. Normotensive individuals had 3 repeated BP
readings averaging less than 140/90 mmHg and no first-degree relative diagnosed with
hypertension before 60 years of age.
As per the original HyperPath study design, participants then completed two dietary phases
which varied in order: (1) high salt diet for 7 days (>200mmol/day sodium) and, (2) low salt
diet for 7 days (10mmol/day sodium). In the current population, a majority of study
participants (92%) underwent the high salt phase first followed by low salt. Both diets also
contained 100mmol/day potassium, 20mmol/day calcium and were isocaloric. Prior to the
current analyses, an examination for an order effect of dietary phase on our outcome
variables was performed. We randomly chose 50 individuals who had completed the high
salt phase first followed by low salt phase and 50 individuals who had completed the low
salt phase first followed by high salt phase. On the final day of each diet week, study
participants were admitted to CRC where they remained fasting and supine overnight.
Assessment of salt balance was determined through a 24-hour urine collection for creatinine
and sodium. The majority of participants completed 7 days of high salt intake while a small
minority completed 5 days. We have shown previously that this variation does not affect the
hormonal or vascular responsiveness.10 Regardless, all study participants were required to
have attained a urine sodium concentration of > 150mmol/day sodium to be included for
analysis. Low salt balance required a concentration of <30mmol/day sodium. BP and
laboratory assessments were performed the following morning between the hours of
8:00-10:00AM with study participants remaining in a supine position overnight for at least 8
hours.
Laboratory Analysis and Measurement of Blood Pressure
Blood for assessment of electrolytes, plasma renin activity (PRA), and serum aldosterone
were collected on ice and centrifuged for 20 minutes. Samples were kept frozen without
preservatives and stored at −80 degrees centigrade until the time of assay. Both PRA and
serum aldosterone were measured in a single centralized core laboratory.
Radioimmunoassay techniques were used to measure aldosterone levels and renin
activity.5, 11, 12 Low renin essential hypertension (LREH) was defined as PRA < 2.5ng
AngI/mL/hr following 90 minutes of upright posture on low salt diet, and non-modulating
(NM) hypertension was defined as an increase in serum aldosterone < 0.42 nmol L−1 after
infusion of angiotensin II [3ng/kg for 60 mins]) while on a low salt diet.13, 14 The clearance
of para-aminohippurate (PAH), infused as a bolus followed by a constant infusion, was used
to assess renal plasma flow, as previously described.5,15 Systolic BP was measured at the
time of PRA assessment and reported as the mean of 5 consecutive readings using an
automated blood pressure monitor (DINAMAP; GE Healthcare, Little Chalfont, United
Kingdom).
SGK1 Genotyping
Single nucleotide polymorphisms (SNPs) were selected from both CEU and YRI
populations of HapMap (Phase II, November 2008) to maximize available variation using
the chromosomal coordinates, chr6: 134,532,082 to 134,537,695 including the 5 kb flanking
regions. Fourteen tagging SNPs–were selected when requiring an r2 > 0.8. Genotyping of
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tthese 14 SNPs was performed in the HyperPath study populations using the Illumina Bead
Station GoldenGate platform (Illumina Inc, San Diego, CA). All SNPs had a genotyping
completion rate of greater than 95%. (Table 1)
Statistical Analysis
Hardy-Weinberg equilibrium (HWE) was assessed for each SNP using χ2 test. The D’ and
r2 measures of linkage disequilibrium (LD) were calculated using Haploview 4.1.16 All tests
for association were performed using SAS version 9.1 (SAS Institute, Cary, NC). Within the
HyperPath population, 7 of the 14 genotyped SNPs displayed minor allele frequencies of
<10% and were not analyzed due to insufficient power. One SNP was not in HWE
(rs1763527) and was also not analyzed. The remaining 6 SNPs captured 85% of the
common variation in this region with an r2>0.9. These remaining 6 SNPs were represented
in 3 unique blocks (ie. 3 SNPs were in LD (rs1743966, rs12663728, rs9402571) and another
set of 2 SNPs were in LD (rs2758150, rs2758152)), and one SNP (rs2758151) was
independent. Thus, three representative SNPs (rs2758151, rs9402571, rs2758152) were used
for the present analysis as they uniquely captured all genetic variation in this region in the
Caucasian HyperPath population. A generalized-estimating-equation (GEE) logistic model
with an exchangeable covariance matrix was used for binary data analyses; and a mixed
effect linear regression model was used for all of the continuous data analyses. GEE and
mixed effect linear regression models were used to adjust for familial relatedness, as some
siblings were present in the study population. All analyses were adjusted for age, gender,
BMI, and study site. In the analysis of delineating the effect of different study diet sequence,
PROC MIXED was used with BP and PRA as outcomes; salt intervention, experimental
period and sequence were represented in the model as fixed effects; whereas study sequence
was included as a random effect to allow for within-individual correlation among
measurements. No indicators revealed effect of diet carryover (experimental period or study
sequence) were significant for SBP(psequence= x0.58, pperiod= 0.23) or PRA(psequence = 0.12,
pperiod = 0.10). Logarithmic transformations were performed for PRA concentrations to
normalize the distribution of data. No evidence of population stratification was observed
based on an analysis of 801 control SNPs in the study population (genomic inflation factor =
1.000).17 Bonferroni correction was applied to account for multiple comparisons. Three
SNPs were evaluated in the index (hypertensive) study population, resulting in a final p-
value for statistical significance of 0.5/3 or 0.017 for the primary outcome of systolic BP.
RESULTS
SGK1 Genotype Is Associated with Higher Blood Pressure in Hypertensive Study
Participants on High Salt Diet
Baseline characteristics of the study populations are shown in Table 1. On a high salt diet,
hypertensive study participants who were homozygous for the rs2758151 or rs9402571
major allele had significantly higher blood pressures compared with study participants
carrying the minor alleles. On a low salt diet there was no association between SGK1
genotype and systolic BP (Figure 1). Consistent with these findings, SGK1 genotype was
significantly associated with the change in systolic BP between dietary phases [change in
systolic BP (±SEM); rs2758151: major allele homozygote 16.3 ± 1.3 mmHg; minor allele
carrier 13.1 ± 1.4 mmHg; minor allele homozygote 9.1 ± 2.9 mmHg, p = 0.004; rs9402571:
major allele homozygote 16.2 ± 1.2 mmHg; minor allele carrier 11.3 ± 1.5 mmHg; minor
allele homozygote 8.9 ± 5.1 mmHg, p= 0.002]. SNP rs2758152 was not associated with
blood pressure on either salt diet. We did not find an effect of order of the dietary
intervention on blood pressure (p = 0.80). Normotensive major allele homozygotes for
SGK1 showed a trend towards higher BP on a high salt diet, albeit not significant
(rs2758151: 109.2 ± 3.3 mmHg; 108.8 ± 3.3 mmHg; 105.3 ± 4.0 mmHg, p = 0.26;
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trs9402571: 109.0 ± 3.2 mmHg; 107.6 ± 3.3 mmHg; 104.8 ± 6.3 mmHg, p = 0.32). Similar
to the hypertensive population, there was no association between SGK1 genotype and BP on
low salt diet (rs2758151: p = 0.67; rs9402571: p = 0.63).
SGK1 Genotype and Renin-Angiotensin-Aldosterone System Activity
Consistent with BP response to dietary salt intake, SGK1 genotype at rs2758151 and
rs9402571 were associated with RAA system response to dietary salt intake. On the low salt
diet, PRA was significantly lower in participants homozygous for the major allele as
compared with minor allele carriers (Figure 2). This difference by genotype was not
observed on a high salt diet [PRA: ng/mL/hour (95% CI); rs2758151: major allele
homozygote 0.42 ng/mL/hour (0.28, 0.63); minor allele carrier 0.50 ng/mL/hour (0.33,
0.75); minor allele homozygote 0.50 ng/mL/hour (0.29, 0.84), p = 0.125; rs9402571: 0.42
ng/mL/hour (0.30, 0.58); 0.45 ng/mL/hour (0.32, 0.65); 0.61 ng/mL/hour (0.28, 1.33), p =
0.264]. We did not find an effect of order of the dietary intervention on PRA (p = 0.65). No
significant association was observed between SGK1 genotype and aldosterone levels on
high or low salt diet (data not shown).
Exploratory analyses
SGK1 Genotype and Renal Plasma Flow—Our primary results indicate that SGK1
genotype predicts the BP and RAA system response to changes in dietary salt. We have
reported altered renovascular sensitivity to salt in human hypertension.18, 19 We explored
whether genotype status would, therefore, be associated with alteration in renovascular
response to dietary salt intake. Renal plasma flow, measured by para-aminohippurate
clearance method, significantly increased from low to high salt intake in this analysis (477.5
± 99.0 ml/min/1.73 m2 vs. 504.3 ± 101.7 ml/min/1.73 m2, p = < 0.0001), as we have
previously reported.20, 21 However, there was no significant association observed between
SGK1 genotype at rs2758151and renal plasma flow on either diet (data not shown).
SGK1 Genotype in Hypertensive Subtypes—SGK1 genotype at rs2758151 did not
predict increased odds for hypertension [OR 1.08 (0.98-1.19); p = 0.11], however it did
identify two well-described salt-sensitive subsets within hypertension, LREH and NM
hypertension Major allele homozygosity at SGK1 was associated with increased odds for
low renin hypertension (OR 2.18; CI 1.36-3.49; p = 0.001) and non-modulating
hypertension (OR 1.56; CI 1.02-2.39; p = 0.04).
DISCUSSION
This is the first human study of hypertension to associate SGK1 genetic variants with blood
pressure and RAA system activity in response to changes in dietary salt. We demonstrated
that two SNPs representing an area including the SGK1 gene are significantly associated
with salt sensitivity of blood pressure in hypertensive individuals. These two SGK1 genetic
variants were associated with an elevated blood pressure on a high salt diet. Further
substantiating the association of these SNPs with salt intake, we demonstrated that the
effects of genotype on blood pressure were abrogated when dietary salt was restricted.
Within the normotensive population, there was also a trend towards higher blood pressure
on high salt diet, however, these findings were not statistically significant given our limited
sample size and lack of sufficient power to detect differences within the normal BP range.
Consistent with an association with salt sensitivity of blood pressure, we observed reciprocal
association with PRA at the same SGK1 variants. The genotype associated with a greater
blood pressure response to dietary sodium manipulation (major allele homozygote at either
rs2758151 or rs9402571) also showed an association with lower PRA as detected on the low
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tsodium diet. This was not discernible under high sodium conditions likely due to
overwhelming suppression of PRA and/or assay limitations at very low PRA levels. Thus, it
appears that renin is appropriately suppressed under conditions of volume expansion as
represented by an increase in blood pressure observed in the major allele homozygote
genotype. Given the well-described interplay between dietary salt intake, mineralocorticoid
activity and SGK1 expression,22 one might anticipate a relationship between aldosterone
and SGK1 genotype. However, despite differences in PRA by genotype we observed no
significant association in aldosterone levels. This could be due to limitations in assay
sensitivity or partial uncoupling of the normal physiologic relationship between renin and
aldosterone secretion.
What might explain the association of salt sensitivity and SGK1 genotype status? We and
others have described that renovascular function is dependent on dietary salt intake, whereby
high salt intake results in increased renal plasma flow.23 Furthermore, loss of this
relationship is seen in salt-sensitive forms of hypertension.13 Thus, we explored whether
renal plasma flow response to dietary salt intake would be associated with SGK1 genotype
and found no difference. This would suggest that despite an increase in BP among major
allele carriers the renal vasculature is not displaying an increased blood flow---similar to
what has been described in salt-sensitive hypertension in general.
Another possible mechanistic explanation for the association of SGK1 genotype with salt
sensitivity of blood pressure can be found by examining renal tubular sodium handling in
animal models. The SGK1 knockout mouse develops hypotension on a low sodium diet due
to an inability to upregulate SGK1-dependent ENaC activity in the renal tubule and increase
sodium reabsorption. Although we could not find a human analog for the SGK1 KO mouse,
our results suggest that the increase in BP on high salt diet in the SGK1 major alleles may
represent increased SGK1 activity. An increase in SGK1 activity could in turn increase
ENaC activity, sodium reabsorption, and contribute to elevated BP.
Close to half of patients with hypertension exhibit some degree of salt sensitivity of blood
pressure.24 Further, salt sensitivity is independently associated with cardiovascular events in
individuals with hypertension and in individuals with normal blood pressure.25, 26 We were
able to detect the association between salt-sensitivity of blood pressure and genotype in
hypertensives in our group. This is consistent with a genetic predisposition to salt sensitivity.
In fact, we found that genotype status was associated with increased odds for two well-
described heritable salt-sensitive groups within the hypertensive population; those with low
renin or those with non-modulating hypertension.14, 27, 28 Other genetic associations have
been observed in these largely heritable subsets including those linked to altered sodium or
volume homeostasis.29-31 Thus, our data support the importance of SGK1 as a candidate
gene in identifying subsets who may benefit from therapies targeting mediators of sodium/
volume homeostasis.
There are several limitations to be noted. First is the inherent inability to demonstrate
causality in a retrospective or cross-sectional analytic approach. This was a tagging SNP
study meant to provide polymorphic genetic coverage in a region of the human genome that
includes SGK1. Thus, we can only describe associations to this region. Fine mapping or
sequencing studies would be required to determine possible functional variants within this
region. These analyses were performed in a modest sized population. We feel that the
rigorous study conditions including a strict dietary salt protocol and medication washout
further strengthen our results. Furthermore, the apparent concordance of results among the
hypertensive and normotensive populations should be interpreted with caution given the
smaller sample size and limited power to detect statistical significance. While we used RAA
system activity as a marker of volume homeostasis, there are multiple other important
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tcontributors to intravascular volume such as the natriuretic peptide system, vasopressin,
sympathetic activity and vascular tone which were not assessed in this study. Further studies
are needed to directly assess SGK1 activity in renal tubules as well as other cell types.
In summary, we found that polymorphisms in the SGK1 gene are associated with blood
pressure response to salt intake and RAA system activity in hypertensives. This may provide
clues to the mechanisms underlying salt-sensitive hypertension and to factors that predispose
to elevated blood pressure within a population. Future studies are needed to clarify this role
and to determine if SGK1 genotype status can identify individuals who will respond
favorably to specific non-pharmacological (salt restriction) and pharmacological approaches
to managing hypertension.
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What is known about topic
SGK1 plays a central role in epithelial sodium channel (ENaC)-dependent Na+
transport in the distal nephron
Mice lacking the SGK1 gene are unable to appropriately increase the expression and
activity of ENaC leading to impaired sodium reabsorption and hypotension on a
sodium restricted diet resulting in sodium dependency to maintain blood pressure.
What this study adds
Polymorphisms in the SGK1 gene are associated with blood pressure response to salt
intake and RAA system activity in hypertensives
SGK1 genotype status may provide clues to the mechanisms underlying salt-
sensitive hypertension and to factors that predispose to elevated blood pressure
within a population
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tFigure 1.
Systolic Blood Pressure on a High Salt Diet Differs by SGK1 genotype within hypertensive
study participants. No difference in BP by genotype on LS diet (p=0.890, p=0.512). 1,1
represents major allele homozygotes. 2,2 represents minor allele homozygotes. Error bars
represent SEM.
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Plasma renin activity (PRA) on a Low Salt Diet differs by SGK1 genotype within
hypertensive study participants. 1,1 represents major allele homozygotes. 2,2 represents
minor allele homozygotes.
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Table 1
Characteristics of study populations
Variable HTN NT
Number 421 152
Low Renin Essential Hypertension (%) 81 (19%)
Non-Modulating Hypertension (%) 106 (25%)
Age (years) 48.4±8.7 39.5±11.0
BMI (kg m−2) 27.5±3.8 24.6±3.9
Gender (% female) 169(40%) 77(51%)
High salt SBP (mmHg) 146.5±19.6 109.9±11.3
High salt DBP (mmHg) 87.9±11.8 66.0±8.1
Low salt SBP (mmHg) 131.3±17.8 106.1±10.6
Low salt DBP (mmHg) 80.5±18.7 63.4±7.3
High salt PRA (ng ml−1 per h) 0.63±0.88 0.46±0.44
Low salt PRA (ng ml−1 per h) 2.58±2.20 2.96±1.94
Aldosterone high salt (nmol L−1) 0.16±0.12 0.11±0.09
Aldosterone low salt (nmol L−1) 0.50±0.35 0.52±0.32
Cholesterol (mmol L−1) 4.99±0.98 4.18±0.89
Triglyceride (mmol L−1) 1.69±1.02 1.12±0.72
HDL (mmol L−1) 1.03±0.32 1.20±0.48
LDL (mmol L−1) 3.13±0.81 2.52±0.70
Data presented as the mean ± standard deviation.
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Table 2
Minor allele frequencies and Hardy-Weinberg Equilibrium p-values
according to HapMap tagging SNPs at SGK1 in the HyperPath group
SNP MAF (HTN) MAF (NT) HW (HTN)
(p-value)
HW (NT)
(p-value)
rs1743966 19% 23% 0.812 0.319
rs12663728 18% 20% 0.421 0.454
rs2758150 10% 10% 0.273 0.649
rs2758151 28% 33% 0.320 0.935
rs2758152 9% 12% 0.330 0.898
rs9402571 18% 19% 0.126 0.390
rs1763527 44% 43% 0.000 0.0002
MAF= minor allele frequency; HTN=hypertensive group; NT=normotensive group; HW=Hardy-Weinberg equilibrium p-value (2-tailed chi2)
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